Literature DB >> 32995039

Utilizing a novel unified healthcare model to compare practice patterns between telemedicine and in-person visits.

Justin G Norden1, Jonathan X Wang1, Sumbul A Desai1, Lauren Cheung1.   

Abstract

OBJECTIVE: Telemedicine practice has been shown to vary from clinical guidelines. Variations in practice patterns may be caused by disruptions in the continuity of care between traditional and telemedicine providers. This study compares virtual and in-person visits in Stanford's ClickWell Care (CWC) - where patients see the same provider for both visit modalities.
METHODS: Clinical data for two years of patient encounters at CWC from January 2015-2017 (5772 visits) were obtained through Stanford STRIDE. For the 20 most common visit categories, including 17 specific diagnoses, we compared the frequency of prescriptions, labs, procedures, and images ordered, as well as rates of repeat visits.
RESULTS: For the 17 specific diagnoses, there are no differences in labs ordered. Two diagnoses show differences in images ordered, and four differences in prescriptions. Overall, there are more labs (0.16 virtual, 0.33 in-person p < 0.0001) and images ordered (0.07 virtual, 0.16 in-person, p < 0.0001) for in-person visits - due mainly to general medical exam visits. Repeat visits were more likely after in-person visits (19% virtual, 38% in-person, p < 0.0001), 10 out of 17 specific diagnoses showed differences in visit frequency between visit modalities. Visits for both anxiety (5.3x, p < 0.0001) and depression (5.1x, p < 0.0001) were much more frequent in the virtual setting.
CONCLUSIONS: Prescriptions, labs, and images ordered were similar between in-person and virtual visits for most diagnoses. Overall however, for in-person visits we find increased orders for labs and images, primarily from general medical exams. Finally, for anxiety and depression patients show clear preferences for virtual visits.
© The Author(s) 2020.

Entities:  

Keywords:  Telemedicine; e-health; m-health; physicians' practice pattern; telehealth

Year:  2020        PMID: 32995039      PMCID: PMC7503002          DOI: 10.1177/2055207620958528

Source DB:  PubMed          Journal:  Digit Health        ISSN: 2055-2076


Introduction

Telemedicine visits are an ever-increasing part of the US healthcare system. Telemedicine dates back to the late 1960’s, however, due to recent changes in technology and reimbursement, telemedicine adoption is accelerating.[1,2] This technology has tremendous potential to reduce healthcare costs and improve access to care for underserved populations.[3,4] Less than 40% of Americans are able to get non-ED after-hours care, and telemedicine has been utilized to provide access to care for such patients.[5-8] Additionally, surveys suggest that up to 72% of consumers would choose to see a doctor virtually.[9] However, there is concern over the quality of care in telemedicine.[10] A recent systematic review showed mixed results for the effectiveness of telemedicine. There is a clear need for larger studies in this evolving and dynamic field.[11] Among the main concerns for telemedicine are changes in practice style and poor clinical outcomes. One study noted lower rates of diagnostic testing in virtual care than in traditional settings.[12] Another recent study highlighted a large variation in quality of care across the 8 different telemedicine companies studied.[13] Large variations in practice and adherence to guidelines are not unique to telemedicine, and have also been found in the traditional primary care setting despite recent advances in clinical decision support.[14,15] Comparing telemedicine to in-person primary care visits is difficult because patient demographics are often variable between virtual visits in an episodic setting and those in a primary care setting. Current studies have been unable to tease out whether differences in practice are due to the modality of the visit, differences in treating physicians, or differences in patient populations. This study compares practice patterns between virtual and in-person visits through Stanford ClickWell Care (CWC).[16] CWC is a novel virtual primary care clinic developed to serve Stanford’s Accountable Care Organization’s (ACO) younger, healthier, and more tech-savvy patient population.[17] This virtual primary care clinic is designed to combine the convenience of telemedicine with the patient rapport developed in a traditional primary care setting. This clinic allows patients to maintain a traditional relationship with a primary care physician, undergo both in-person and virtual (phone or video) visits, and receive on-demand care at extended hours. We believe this is an ideal way to compare practice patterns across different care delivery modalities.

Materials and methods

Participants

Participants were those who completed any encounter with CWC MD provider between January 2015 and January 2017. All patients at CWC were enrolled in the study, which was approved by the Stanford University Institutional Review Board. Demographic analysis of these patients can be found in our previous study.[16] Patients eligible to sign up for CWC were Stanford Employees enrolled in Stanford's ACO. Inclusion criteria were: age ≥18 years, and English language proficiency. Patients were excluded based on any hospitalization in the past year for chronic medical conditions such as uncontrolled diabetes or hypertension, coronary artery disease, stroke, or another serious medical issue as measured by a health risk assessment (HRA). The HRA (Supplemental Material 1) was created to standardize recommendations to primary care clinic based on health risk and preference. Patients with scores of 0–4 were offered CWC; scores of 5–10 were offered traditional primary care, and scores >12 were offered Stanford Coordinated Care, a clinic for patients requiring a higher level of care coordination. No patients were excluded for mental health challenges.

Data

Data were pulled through the STRIDE database, a database containing EMR records from Stanford Health Care's version of EPIC.[18] Data includes the following patient demographics: age, sex, race, ethnicity, and distance to clinic. We filtered EMR visit data to include: date, time, modality, diagnosis, tests ordered, and medications prescribed. Visit encounter data was pulled for visits completed between January of 2015 and January of 2017. All participant data was de-identified.

Analysis

ICD-9 codes were grouped into clinically meaningful condition categories using the 2012 National Ambulatory Medical Care Survey (NAMCS) and Medicare Chronic Conditions Warehouse.[19,20] The top 20 most common categories were determined by number of visits to CWC. This included 17 specific diagnoses and three other categories of visits not focused on a specific diagnosis, “general medical exam,” “gynecological exam,” and “specific procedure or aftercare.” Prescriptions, labs, procedures, and images ordered were captured for in-person and virtual visits. Virtual visits were defined as telephone or video visits between a patient and MD provider. In-person visits were defined as those that happened in the brick and mortar CWC between a patient and an MD provider. To capture prescription patterns, the top three prescriptions by frequency prescribed were determined for each condition category. Drugs were grouped into broad classes following the AHFS Pharmacologic-Therapeutic classification.[21] The frequency of prescriptions was defined as the percent of visits with a prescription for the drug in question, over all visits within the condition category. These frequencies were tested for significant differences between virtual and in-person modalities with a t-test. Additionally, the frequency of labs, procedures, and images ordered were taken for each condition category. These frequencies were compared between virtual and in-person visits for each condition with a t-test. Repeat visits for condition categories were analyzed for both virtual and in-person visits. A repeat visit was determined as any encounter with an in-network provider (including labs, phone calls, or other interactions) within one or three days, after an initial virtual or in-person visit to CWC. This definition of a repeat visit is broad, including return visits ordered at the initial visit (e.g. radiology) or visits to other providers that may be unrelated to the chief complaint. One or three day time points were chosen based on discussions with clinicians and perceived windows of time they thought may be unusual following a normal visit. The repeat visit frequencies were tested for significant differences between virtual and in-person differences with a two-sided t-test.

Software

Data processing and programs are written in Python 2.7 (Python Software Foundation, Beaverton, OR).[22] Data visualization, regressions analyses, model selection and statistical adjustments are made using R 3.12 (The R Project for Statistical Computing, Vienna, Austria).[23]

Results

The 20 most common condition categories were determined using all visits to CWC. Gynecological exam was removed from the diagnoses list due to having no virtual visits, despite being amongst the top 20 condition categories. After filtering for the top 20 condition categories, this resulted in 3993 unique visits that were completed over two years from January 2015-January 2017 at CWC. Table 1 shows the number and frequency of visits by visit category, as well as the average number of labs and images ordered. Virtual visits are significantly more frequent for eight condition categories (acquired hypothyroidism, acute upper respiratory infections excluding pharyngitis, anemia, anxiety disorders, depression, disorders of lipid metabolism, normal pregnancy, and spinal disorders). In-person visits are significantly more frequent for three condition categories (acute pharyngitis, otitis media and eustachian tube disorders, and the general medical examination). Visits for anxiety and depression were 5.3x and 5.1x more frequent in the virtual setting (p < 0.0001, p < 0.0001).
Table 1.

Number and frequency of visits by diagnosis, and associated average numbers of labs and images ordered

Number of VisitsLab Orders (avg)Imaging (avg)
ConditionsVirtualClinicpVirtualClinicpVirtualClinicp
Acquired hypothyroidism33 (3.2%)19 (1.3%) 0.0027 0.3030.3160.94930.0610.1050.5977
Acute pharyngitis40 (3.9%)82 (5.7%) 0.0347 0.1250.2070.5470.0000.000NA
Acute upper respiratory infections excluding pharyngitis132 (12.8%)85 (5.9%) 1E-08 0.0230.1290.09630.0000.0240.1585
Anemia16 (1.6%)8 (0.6%) 0.0212 0.1880.5000.20040.0630.0000.3332
Anxiety disorders61 (5.9%)16 (1.1%) 1E-09 0.0330.1250.47860.0160.0000.3213
Arthropathies and related disorders108 (10.5%)129 (9%)0.21050.1480.1240.74080.2130.550 3E-05
Asthma20 (1.9%)15 (1%)0.0760.0000.1330.16430.0500.1330.4301
Benign neoplasms16 (1.6%)18 (1.3%)0.53170.3750.4440.83490.0630.0560.9343
Depression90 (8.7%)24 (1.7%) 1E-13 0.2330.4170.52290.0110.0420.4848
Disorders of lipid metabolism31 (3%)22 (1.5%) 0.0176 0.6450.9550.58070.0320.1360.3298
Essential hypertension54 (5.2%)53 (3.7%)0.06780.5370.4150.68360.0560.0750.6809
General medical examination155 (15.1%)593 (41.2%) 2E-50 0.1230.481 2E-07 0.0260.091 0.0003
Heart disease excluding ischemic7 (0.7%)9 (0.6%)0.86911.5710.3330.46430.0000.000NA
Normal pregnancy19 (1.8%)8 (0.6%) 0.0054 0.1050.2500.60580.0000.1250.3506
Obesity5 (0.5%)14 (1%)0.1490.0000.0710.33560.0000.000NA
Otitis media and eustachian tube disorders8 (0.8%)28 (1.9%) 0.0104 0.2500.1070.59980.0000.0360.3262
Rheumatism, excluding back71 (6.9%)89 (6.2%)0.48360.0700.1240.48680.1970.3370.0937
Specific procedures and aftercare20 (1.9%)21 (1.5%)0.36590.0000.0950.16230.0000.0950.1623
Spinal disorders141 (13.7%)122 (8.5%) 6E-05 0.0990.1560.57820.1060.311 0.0004

Note: Disease condition categories formed from ICD-9 code groupings found in the 2012 National Ambulatory Medical Care Survey (NAMCS) and Medicare Chronic.

Conditions Warehouse.

Bold: p < 0.05.

Number and frequency of visits by diagnosis, and associated average numbers of labs and images ordered Note: Disease condition categories formed from ICD-9 code groupings found in the 2012 National Ambulatory Medical Care Survey (NAMCS) and Medicare Chronic. Conditions Warehouse. Bold: p < 0.05. For the 17 specific diagnoses, the tests ordered are highly similar. There are no significant differences in labs ordered. For imaging, there are two conditions with differences, arthropathies (p < 0.0001) and spinal disorders (p = 0.0004), with in-person visits having more orders. For categories not focused on a specific diagnosis, specific procedures and aftercare showed no differences while general medical exam showed a 3.9x increase in lab orders (p < 0.0001) and a 3.5x (p < 0.0001) increase in imaging for the in-person visits. For all visits combined there are significantly more labs (0.16 virtual, 0.33, in-person, p < 0.0001) and images ordered (0.07 virtual, 0.16 in-person, p < 0.0001) for in-person visits. For procedures analyzed, due to low numbers of procedures per diagnosis, few statistically relevant results can be drawn, thus we have omitted these findings from the study. Table 2 shows the prescription patterns of the most frequently prescribed drugs for each condition category. If a drug class had less than 5 orders, it was removed from the analysis due to being underpowered; this left 39 total drug classes. Overall there were a few significant differences captured in prescription patterns between virtual and in-person visits. These significant differences include the following: antibiotics were more commonly prescribed for otitis media at in-person visits as the most prescribed drug class (43% vs 0% p = 0.0001). Muscle relaxants were more commonly prescribed for spinal disorders at in-person visits as the most prescribed drug class (26% vs 15% p = 0.02). Skin prep were more commonly prescribed for arthropathies and related disorders at in-person visits as the 2nd most prescribed drug class (5% vs 1% p = 0.04, skin prep drug category includes most all topical medications). CNS drugs were more commonly prescribed for anxiety disorders at virtual visits as the 3rd most prescribed drug class (0% vs 8% p = 0.02). In three out of four of these significant differences, in-person visits had more prescriptions. However, the number of significant differences is small in comparison to the number of prescriptions analyzed, and the cumulative frequency of prescriptions was similar between modalities.
Table 2.

Top three prescriptions and frequencies of prescription for visits by diagnosis between virtual and in-person visits.

 Rx1
#Rx (%visits with Rx)
Rx2
#Rx (%visits with Rx)
Rx3
#Rx (%visits with Rx)
ConditionsPrescriptionVirtualClinicpPrescriptionVirtualClinicpPrescriptionVirtualClinicp
Acquired hypothyroidismThyroid Prep52% (17)42% (8)0.5559Psychotherapeutics12% (4)5% (1)0.447Gastrointestinal9% (3)5% (1)0.603
Acute pharyngitisAntibiotics20% (8)21% (17)0.9258Hormones5% (2)2% (2)0.513Biologicals5% (2)1% (1)0.312
Acute upper respiratory infections excluding pharyngitisCough Cold23% (31)27% (23)0.6432Antibiotics23% (30)24% (20)0.896Eent prep14% (19)24% (20)0.164
Anxiety disordersPsychotherapeutics90% (55)88% (14)0.8837Analgesics0% (0)13% (2)0.164Cns drugs8% (5)0% (0)0.024
Arthropathies and related disordersAntiarthritics3% (3)7% (9)0.1585Skin prep1% (1)5% (7)0.043Eent prep5% (5)0% (0)0.132
AsthmaAntiasthmatics80% (16)100% (15)0.4641Hormones40% (8)20% (3)0.206Antibiotics5% (1)20% (3)0.218
DepressionPsychotherapeutics57% (51)75% (18)0.2043Contraceptives3% (3)8% (2)0.417Gastrointestinal2% (2)8% (2)0.315
Disorders of lipid metabolismCardiovascular52% (16)32% (7)0.2707Biologicals3% (1)9% (2)0.412Gastrointestinal0% (0)9% (2)0.162
Essential hypertensionCardiovascular43% (23)60% (32)0.1392Cardiac6% (3)15% (8)0.108Diuretics11% (6)9% (5)0.778
General medical examinationAntiasthmatics8% (13)3% (17)0.079Skin prep6% (9)4% (25)0.481Contraceptives4% (6)6% (33)0.352
Otitis media and eustachian tube disordersAntibiotics0% (0)43% (12) 0.0001 Antiasthmatics38% (3)0% (0)0.197Cough cold25% (2)11% (3)0.433
Rheumatism, excluding backAntiarthritics4% (3)11% (10)0.0922Psychotherapeutics3% (2)7% (6)0.24Biologicals1% (1)3% (3)0.495
Spinal disordersMuscle Relaxants15% (21)26% (32) 0.0244 Antiarthritics15% (21)11% (13)0.318Analgesics9% (12)15% (18)0.15

Total number of initial virtual visits for the recorded conditions (944); total number of intitial in-person visits (1277).

Removed Anemia, Benign neoplasms, Gynecological examination, Heart disease excluding ischemic, Normal pregnancy, Obesity, Specific procedures and aftercare due to statistically insignificant low Rx counts (<5)

Drug classes are grouped following the AHFS Pharmacologic-Therapeutic Classification system.

Bold: p < 0.05

Top three prescriptions and frequencies of prescription for visits by diagnosis between virtual and in-person visits. Total number of initial virtual visits for the recorded conditions (944); total number of intitial in-person visits (1277). Removed Anemia, Benign neoplasms, Gynecological examination, Heart disease excluding ischemic, Normal pregnancy, Obesity, Specific procedures and aftercare due to statistically insignificant low Rx counts (<5) Drug classes are grouped following the AHFS Pharmacologic-Therapeutic Classification system. Bold: p < 0.05 Table 3 shows repeat visit rates by condition category following a virtual or in-person visit to CWC. This is done at both a 1-day and 3-day time scale. A high % signifies a higher rate of repeat visits to CWC or another provider in the Stanford ACO within a 1 or 3 day time window following a virtual or in-person visit. For the 1-day time window, 6 of the 19 condition categories (acute pharyngitis, anemia, arthropathies and related disorders, benign neoplasms, rheumatism excluding back, spinal disorders) were found to have a significantly lower rate of repeat visits for virtual visits, with an overall average of 19% for virtual visits and 38% for in-person visits (p < 0.0001). One condition category, acute pharyngitis had a higher repeat visit rate for virtual visits (40% vs 21% p = 0.037). For the 3-day time window, 5 of the 19 condition categories (arthropathies and related disorders, benign neoplasms, rheumatism excluding back, spinal disorders, and general medical exam) were found to have a significantly lower repeat visit rate in virtual visits, with an overall average of 28% for virtual and 44% for in-person (p < 0.0001). One condition category, acute pharyngitis, had a higher repeat visit rate for virtual visits (53% vs 28% p = 0.011).
Table 3.

Repeat visit rates between virtual and in-person visits at both 1 day and 3 day intervals.

1-day 3-day
ConditionsVirtualIn-personpVirtualIn-personp
Acquired hypothyroidism9%32%0.07427%37%0.4935
Acute pharyngitis40%21% 0.0369 53%28% 0.0115
Acute upper respiratory infections excluding pharyngitis7%2%0.106414%9%0.2612
Anemia25%75% 0.0247 44%75%0.1528
Anxiety disorders13%13%0.949418%19%0.9496
Arthropathies and related disorders26%52% 3E-05 31%57% 5E-05
Asthma10%40%0.055135%40%0.7715
Benign neoplasms0%39% 0.0043 0%39% 0.0043
Depression17%33%0.125927%42%0.1934
Disorders of lipid metabolism26%32%0.644235%41%0.6968
Essential hypertension19%26%0.332826%26%0.9546
General medical examination21%44% 4E-09 26%51% 3E-09
Heart disease excluding ischemic14%44%0.204314%44%0.2043
Normal pregnancy47%63%0.498958%75%0.4083
Obesity20%43%0.373340%43%0.9219
Otitis media and eustachian tube disorders13%7%0.699313%14%0.9021
Rheumatism, excluding back21%43% 0.0031 30%46% 0.0319
Specific procedures and aftercare25%29%0.802335%38%0.8419
Spinal disorders21%40% 0.0009 30%44% 0.0217

Bold: p < 0.05

Repeat visit rates between virtual and in-person visits at both 1 day and 3 day intervals. Bold: p < 0.05

Discussion

As telemedicine adoption continues to rise,[24] it is of increasing importance to understand what factors contribute to effective, high quality telemedicine. One specualted contributor to lower quality of virtual care is fragmentation[25]–patients may benefit from continuity of care when seeing an in-person traditional primary care doctor. This is the first study to our knowledge that uses a unified in-person and virtual health system to examine similarities and differences in practice patterns between the two modalities. Other studies have looked at physician practices from separate in-person or virtual care clinics, but none offer care from the same physician in both modalities.[4,12,26] Our results show largely similar practice patterns for most conditions between modalities within CWC. For all 17 specific diagnoses there are no differences in labs ordered, only two conditions differed in images ordered, and only four in prescriptions written. There are, however, a number of important differences. In the case of a general medical exam (where visits focused on no specific diagnosis) there is a four-fold increase in labs and a more than three-fold increase in images ordered for in-person visits. The reason for this is unknown, but may reflect physician’s perception that patients choosing in-person visits are expecting a more comprehensive examination. Alternatively, patients may choose to come in in-person if they want labs or images to be taken. Patients and providers appear to have strong preferences for a given modality dependent on the service desired. For example, general medical exams are 2.7x more frequent in-person whereas psychiatric conditions, anxiety and depression, both are 5x more frequent virtually. We believe the differences in general checkup preferences may be explained by providers who find general checkups to be more efficient in-person. The differences for virtual visits in psychiatric conditions is particularly striking. These findings suggest that providers may find mental health encounters more suitable for virtual modalities. It also suggests the existing hypothesis that patients may be more comfortable speaking with their providers about mental health issues through virtual interfaces.[27,28] Recent studies have also reported that telemedicine is particularly effective in neurology or psychiatry settings.[29-31] Another notable finding is that lab and imaging orders are relatively similar between modalities for the vast majority of conditions. For labs, the only significant difference found is for the general medical examination (where no specific diagnosis is noted) where in-person visits recorded many more tests. For the other 17 specific diagnoses there were no significant differences in lab orders. A similar result is found for imaging, where only 2 of 17 specific diagnoses had significantly different imaging frequencies. Cumulatively, we did find an increase in frequency of labs and images ordered in-person. This is primarily due to the large increase in labs and images ordered for the in-person general medical exam, which contribute to a large proportion of visits (41% in-person,15% virtual). Because of this, the overall average for lab orders was relatively lower in virtual visits. This coincides with recent literature that has found similar decreases in diagnostic tests in telemedicine practice.[12,13,32,33] Prescription patterns between modalities are similar as well, this coincides well with recent literature that has found a similar relationship with antibiotic prescription rates.[32,34] We propose several possible explanations for the few different prescription practice patterns. For otitis media, it is standard protocol to examine the ear before prescribing antibiotics. The greater number of antibiotic prescriptions for in-person visits is a reflection of physicians following standard of care protocol. For spinal disorders, a physician is likely more comfortable prescribing muscle relaxants if they can perform more thorough physical exams. For arthropathies and related disorders, skin prep was likely prescribed at a higher frequency due to a more thorough skin exam, however this is generally not the main concern for treatment or diagnosis. When in-person, physicians may be more likely to detect these unrelated skin issues and prescribe skin prep. For anxiety, as previously discussed, patients may feel more comfortable talking about their concerns over virtual interfaces and be more likely to receive CNS drugs. Overall, there very few significant differences in prescription patterns. For the few that are present, we see that they are likely a result of the inherent differences between the modalities of care. Finally, we find repeat visits are more likely after in-person visits. Six condition categories have statistically higher repeat visit rates for in-person visits, whereas only one condition category has higher repeat visit rates for virtual visits (1-day windows). This possibly reflects higher acuity concerns associated with in-person visits, but we have no data on reasons for choice of modality. Interestingly, these differences in repeat visit rates suggest that virtual visits are not perceived to be “incomplete” (or in need of follow-up for further investigation) when compared to in-person visits. Our post-visit utilization analysis may not capture the underlying reason for a follow-up visit, as we count any interaction within the network (phone call, labs, primary care appointment, etc.) as a visit, which explains some of the high frequency values seen. However, we believe these are still important and interesting initial findings that prompts further future research in other study designs.

Limitations

First, practice patterns were only able to be elucidated retrospectively from the data captured through the stride database. Thus, broader practice patterns were investigated rather than individual visits. In addition, with only 2 years of data in one clinic, some statistical tests were underpowered due to low N, and may have reached significance with more data. Low N also prevented us from being able to perform a demographics analysis by diagnosis, though we have done an in-depth analysis in previous papers on the general CWC population.[16] Another limitation is that the differences in practice patterns we find were not able to be analyzed in relation to outcome or patient satisfaction. For example, we were not able to look at physician’s adherence to guidelines-based practice and therefore cannot speak to the appropriateness of the labs or prescriptions ordered. Because of this, it is difficult to draw conclusions about whether certain practice patterns are better or worse. Moreover, these differences in practice patterns may be a result of selection bias rather than modality, as we are unable to control for patient choice in the study. Our analysis of repeat vists may not be a true proxy for utilization of follow-up vists. Our study uses a broad definition of repeat visits, thus visits for radiology or visits to providers unrelated to the chief complaint (routine physical therapy, behavioral health, ore other weekly apointments) may confound the analysis. Finally, these results may not be generalizable due to the specific ACO population from a generally healthy young Stanford employee population, especially in regards to education and technology acceptance.

Conclusions

This is the first study, to our knowledge, to compare practice patterns for virtual and in-person appointments where patients see the same provider for each type of visit. Overall, prescription patterns, as well as lab, procedures, and images ordered were similar between in-person and virtual visits for most diagnostic groups. However, there was a higher rate of repeat visits in the in-person setting. Finally, this study highlights a difference seen in care surrounding depression. Depressed patients are more likely to choose virtual visits, and those that were seen with this modality had less repeat visits as well. Future studies may include the collection of more data over the years and following trends longitudinally. In addition, studies may perform further exploratory data analysis to identify hidden associations and trends within the data such as sociodemographic analyses. With certain large healthcare providers anticipating more telemedicine visits than in-person visits in 2020, it will be essential that this imminent technology is studied carefully to ensure the highest quality of care. Click here for additional data file. Supplemental material, sj-pdf-1-dhj-10.1177_2055207620958528 for Utilizing a novel unified healthcare model to compare practice patterns between telemedicine and in-person visits by Justin G Norden, Jonathan X Wang, Sumbul A Desai and Lauren Cheung in Digital Health
  23 in total

1.  Quality of health care delivered to adults in the United States.

Authors:  J Richard Goss; Joann G Elmore; Daniel S Lessler
Journal:  N Engl J Med       Date:  2003-11-06       Impact factor: 91.245

2.  STRIDE--An integrated standards-based translational research informatics platform.

Authors:  Henry J Lowe; Todd A Ferris; Penni M Hernandez; Susan C Weber
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

3.  Telemedicine as a means of delivering cognitive-behavioural therapy to rural and remote mental health clients.

Authors:  Lucille Griffiths; Ilse Blignault; Peter Yellowlees
Journal:  J Telemed Telecare       Date:  2006       Impact factor: 6.184

4.  Having a usual source of care reduces ED visits.

Authors:  Stephen M Petterson; David Rabin; Robert L Phillips; Andrew W Bazemore; Martey S Dodoo
Journal:  Am Fam Physician       Date:  2009-01-15       Impact factor: 3.292

5.  National telemedicine initiatives: essential to healthcare reform.

Authors:  Rashid L Bashshur; Gary W Shannon; Elizabeth A Krupinski; Jim Grigsby; Joseph C Kvedar; Ronald S Weinstein; Jay H Sanders; Karen S Rheuban; Thomas S Nesbitt; Dale C Alverson; Ronald C Merrell; Jonathan D Linkous; A Stewart Ferguson; Robert J Waters; Max E Stachura; David G Ellis; Nina M Antoniotti; Barbara Johnston; Charles R Doarn; Peter Yellowlees; Steven Normandin; Joseph Tracy
Journal:  Telemed J E Health       Date:  2009 Jul-Aug       Impact factor: 3.536

6.  Antibiotic Prescribing for Acute Respiratory Infections in Direct-to-Consumer Telemedicine Visits.

Authors:  Lori Uscher-Pines; Andrew Mulcahy; David Cowling; Gerald Hunter; Rachel Burns; Ateev Mehrotra
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

7.  Neural Networks for Clinical Order Decision Support.

Authors:  Jonathan X Wang; Delaney K Sullivan; Adam J Wells; Alex C Wells; Jonathan H Chen
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2019-05-06

8.  Analysis of Teladoc use seems to indicate expanded access to care for patients without prior connection to a provider.

Authors:  Lori Uscher-Pines; Ateev Mehrotra
Journal:  Health Aff (Millwood)       Date:  2014-02       Impact factor: 6.301

9.  Adoption of ICU telemedicine in the United States.

Authors:  Jeremy M Kahn; Brandon D Cicero; David J Wallace; Theodore J Iwashyna
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

10.  Crossing the telemedicine chasm: have the U.S. barriers to widespread adoption of telemedicine been significantly reduced?

Authors:  Cynthia LeRouge; Monica J Garfield
Journal:  Int J Environ Res Public Health       Date:  2013-11-28       Impact factor: 3.390

View more
  4 in total

1.  Physicians' Perceptions of Telemedicine Use During the COVID-19 Pandemic in Riyadh, Saudi Arabia: Cross-sectional Study.

Authors:  Sarah Idriss; Abdullah Aldhuhayyan; Ahmad Abdullah Alanazi; Walaa Alasaadi; Reem Alharbi; Ghadah Alshahwan; Mohammad Baitalmal; Wadi Alonazi
Journal:  JMIR Form Res       Date:  2022-07-12

2.  Antibiotic prescribing for acute infections in synchronous telehealth consultations: a systematic review and meta-analysis.

Authors:  Mina Bakhit; Emma Baillie; Natalia Krzyzaniak; Mieke van Driel; Justin Clark; Paul Glasziou; Christopher Del Mar
Journal:  BJGP Open       Date:  2021-12-14

3.  Outpatient antibiotic prescribing for common infections via telemedicine versus face-to-face visits: Systematic literature review and meta-analysis.

Authors:  Hiroyuki Suzuki; Alexandre R Marra; Shinya Hasegawa; Daniel J Livorsi; Michihiko Goto; Eli N Perencevich; Michael E Ohl; Jennifer DeBerg; Marin L Schweizer
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-08-31

4.  Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience.

Authors:  Timothy D Malouff; Sarvam P TerKonda; Dacre Knight; Abd Moain Abu Dabrh; Adam I Perlman; Bala Munipalli; Daniel V Dudenkov; Michael G Heckman; Launia J White; Katey M Wert; Jorge M Pascual; Fernando A Rivera; Michelle M Shoaei; Michelle A Leak; Anna C Harrell; Daniel M Trifiletti; Steven J Buskirk
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.